Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Tech Gazette.
Press releases published on May 15, 2025
Odysight.ai Reports Financial Results for The First Quarter of 2025 and Provides Business Update
GlobeNewswire
·
May 15, 2025
OMER, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (NASDAQ: ODYS), a leading provider of visual based predictive maintenance (PdM) and condition-based monitoring (CBM) solutions, announces its financial results for the three months ended March …
Longevity Health Holdings Announces Business Updates
GlobeNewswire
·
May 15, 2025
PITTSBURGH and GAITHERSBURG, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on extending human longevity and healthy aging through technologically innovative and clinically proven products in …
OSS Appoints Lieutenant General David Bassett (Ret.) Board Member
GlobeNewswire
·
May 15, 2025
Former Director of the Defense Contract Management Agency brings decades of defense acquisition and modernization expertise to support OSS’s AI and edge compute growth opportunities ESCONDIDO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. …
Duos Edge AI Confirms EDC Deployment Goal in 2025
GlobeNewswire
·
May 15, 2025
JACKSONVILLE, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), through its operating subsidiary Duos Edge AI, Inc. (“Duos Edge AI”), a provider of adaptive, versatile and streamlined Edge Data …
BombBomb Launches Engage, a New Video Messaging Platform
GlobeNewswire
·
May 15, 2025
COLORADO SPRINGS, Colo., May 15, 2025 (GLOBE NEWSWIRE) -- BombBomb, the video messaging company for sales professionals, announces the launch of Engage, an enterprise-class platform designed to help sales pros cut through inbox noise with face-to-face …
Reflect Scientific Advances Market Presence by Transitioning from OTCQB to OTCIQ
GlobeNewswire
·
May 15, 2025
OREM, Utah, May 15, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of innovative cryogenic technologies for the life sciences and biotech industries, today announced that it is actively transitioning from the OTCQB Venture …
Moore & Giles Elevates Customer Experience and Brand Agility with BigCommerce
GlobeNewswire
·
May 15, 2025
AUSTIN, Texas, May 15, 2025 (GLOBE NEWSWIRE) -- BigCommerce (Nasdaq: BIGC), an open SaaS, composable ecommerce platform for fast-growing and established B2C and B2B brands and retailers, today announced that Moore …
Pacira BioSciences Presents New Data on the Effects of Clinical Immunogenicity on Locally Administered PCRX-201 in Patients with Moderate to Severe Osteoarthritis of the Knee
GlobeNewswire
·
May 15, 2025
-- Early clinical data indicates that Pre-existing and treatment-induced anti-Ad5 neutralizing antibodies do not impact the safety and effectiveness of PCRX-201 – -- An oral presentation of the data to be featured at the ASGCT Annual Meeting -- BRISBANE, …
Cidara Therapeutics to Host Virtual R&D Day to Discuss CD388 as a Potential Universal, Once-Per-Flu Season Preventative of Seasonal and Pandemic Influenza on May 22, 2025
GlobeNewswire
·
May 15, 2025
SAN DIEGO, May 15, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that it will host a …
First Procedures Completed with EndoQuest’s Endoluminal Surgical System in PARADIGM Trial
GlobeNewswire
·
May 15, 2025
Houston, TX, May 15, 2025 (GLOBE NEWSWIRE) -- EndoQuest Robotics, Inc., a pioneering leader in the development of endoluminal robotic surgical technology, announced today the completion of the first procedures of its pivotal clinical trial, Prospective …
Soleno Therapeutics Announces Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at PES 2025
GlobeNewswire
·
May 15, 2025
REDWOOD CITY, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced poster presentations from its VYKATTM XR …
Cerence to Participate in Two Upcoming Investor Conferences
GlobeNewswire
·
May 15, 2025
BURLINGTON, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that the company will participate in two upcoming investor conferences. …
Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
GlobeNewswire
·
May 15, 2025
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Pathos AI, a leading AI-driven biotech company applying cutting-edge artificial intelligence to drug development, today announced its $365 million Series D financing, bringing its post-money valuation to …
Cocrystal Pharma Reports First Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
GlobeNewswire
·
May 15, 2025
In vitro testing with CDI-988 demonstrated superior broad-spectrum antiviral activity against major norovirus variants BOTHELL, Wash., May 15, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial …
HVR Launches “Utility Now!” Campaign at the Debut of Global Web3 Event Series — Not the One to Miss
GlobeNewswire
·
May 15, 2025
TORONTO, May 15, 2025 (GLOBE NEWSWIRE) -- As Consensus Toronto draws the world’s leading voices in blockchain and decentralized finance, Not the One to Miss is where many of Web3’s most ambitious builders and personalities will be heading after hours. …
Nuvini Group Completes Acquisition of B2B SaaS Platform Munddi
GlobeNewswire
·
May 15, 2025
~ Successfully Marks the First of Four Anticipated Acquisitions in 2025 ~ ~ Creates New Synergies to Drive Revenue Growth and Enhance NVNI’s Ecosystem of B2B SaaS Solutions across Latin America ~ NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Nuvini Group …
Vaxart Receives BARDA Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial
GlobeNewswire
·
May 15, 2025
SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it has received approval from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic …
Christophe Girardier, CEO of Glimpact, to Speak at Three Public Events During hub.brussels’ Impact Mission 2025 in New York
GlobeNewswire
·
May 15, 2025
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Christophe Girardier, CEO of Glimpact the first platform for analyzing the overall systemic environmental impact of products and organizations, will speak at three public events hosted by hub.brussels during …
Immutep’s Efti with KEYTRUDA® (pembrolizumab) & Chemotherapy Achieves High Response Rates in First-Line Non-Small Cell Lung Cancer
GlobeNewswire
·
May 15, 2025
Novel combination achieves 60.8% response rate and 90.2% disease control rate in first-line non-small cell lung cancer (1L NSCLC) Notably, ~92% of all evaluable patients have PD-L1 TPS <50%, including 43% with PD-L1 below 1 (TPS <1%), who represent an area …
Opus Genetics Announces Financial Results for First Quarter 2025 and Provides Corporate Update
GlobeNewswire
·
May 15, 2025
ARVO presentation highlights 12-month results from Phase 1/2 study that support potential of OPGx-LCA5 gene therapy to restore meaningful vision Pediatric cohort of LCA5 study ongoing with initial multi-patient data anticipated in Q3 2025 OPGx-BEST1 on …